LENZ Therapeutics, Inc. (LENZ) Q4 2024 Annual Earnings
LENZ·Reported March 19, 2025·After market close
Diluted EPS came in at $-0.46, missed the $-0.42 consensus by $0.04.
Diluted EPS
$-0.46missed by $0.04
Consensus: $-0.42
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about LENZ Therapeutics, Inc.'s Q4 2024 earnings report.
LENZ Therapeutics, Inc. (LENZ) reported Q4 2024 earnings on March 19, 2025 after market close.
LENZ Therapeutics, Inc. reported diluted EPS of $-0.46 for Q4 2024.
EPS missed the consensus estimate of $-0.42 by $0.04.
You can read the 10-K periodic report (0001815776-25-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.